{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:08:19Z","timestamp":1791875299429,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201906210053"],"award-info":[{"award-number":["201906210053"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["CRC1066-2\/-3"],"award-info":[{"award-number":["CRC1066-2\/-3"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jconrel.2023.02.021","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T12:10:09Z","timestamp":1677586209000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Polysarcosine-based lipid formulations for intracranial delivery of mRNA"],"prefix":"10.1016","volume":"356","author":[{"given":"Dongdong","family":"Bi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis Mark","family":"Unthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Bussmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Remaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Barz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.02.021_bb0005","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Collaborators","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0010","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/15476286.2021.2021650","article-title":"RNA-based therapeutics for neurological diseases","volume":"19","author":"Anthony","year":"2022","journal-title":"RNA Biol."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120681","article-title":"Treatment of ischemic neuronal death by introducing brain-derived neurotrophic factor mRNA using polyplex nanomicelle","volume":"270","author":"Fukushima","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.omto.2021.12.010","article-title":"Intracranial delivery of synthetic mRNA to suppress glioblastoma","volume":"24","author":"Peng","year":"2022","journal-title":"Mol. Ther. Oncoly."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0030","series-title":"Liposomal Drug Delivery to the Central Nervous System","first-page":"213","author":"Nieto Montesinos","year":"2017"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ddtec.2016.07.005","article-title":"Liposome technologies and drug delivery to the CNS","volume":"20","author":"Rip","year":"2016","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0040","doi-asserted-by":"crossref","first-page":"10938","DOI":"10.1021\/acs.chemrev.5b00046","article-title":"New developments in liposomal drug delivery","volume":"115","author":"Pattni","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0045","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1248\/cpb.c20-00041","article-title":"Recent strategies for targeted brain drug delivery","volume":"68","author":"Ogawa","year":"2020","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0050","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1007\/s11033-019-04983-5","article-title":"Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients","volume":"46","author":"Duma","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0055","article-title":"Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines","volume":"9","author":"Thi","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0060","doi-asserted-by":"crossref","first-page":"e2000673","DOI":"10.1002\/smll.202000673","article-title":"Safety considerations of cancer nanomedicine-a key step toward translation","volume":"16","author":"Liu","year":"2020","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0065","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.nucmedbio.2009.02.004","article-title":"[(186)Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model","volume":"36","author":"Soundararajan","year":"2009","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0070","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid NanoparticlesFrom Liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0075","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/14686996.2019.1590126","article-title":"Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a review","volume":"20","author":"Shiraishi","year":"2019","journal-title":"Sci. Technol. Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0080","article-title":"Suspicions grow that nanoparticles in Pfizer\u2019s COVID-19 vaccine trigger rare allergic reactions","author":"Vrieze","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0085","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1021\/acs.molpharmaceut.5b00144","article-title":"Anti-PEG IgM is a major contributor to the accelerated blood clearance of polyethylene glycol-conjugated protein","volume":"12","author":"Mima","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jconrel.2021.11.042","article-title":"Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement","volume":"341","author":"Estap\u00e9 Senti","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0095","doi-asserted-by":"crossref","first-page":"10748","DOI":"10.1039\/D1NR02065J","article-title":"Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery","volume":"13","author":"Shi","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0100","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jconrel.2005.04.003","article-title":"Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes","volume":"105","author":"Ishida","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0105","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1021\/acsnano.1c05922","article-title":"Polyethylene glycol immunogenicity: theoretical, clinical, and practical aspects of anti-polyethylene glycol antibodies","volume":"15","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0110","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.7150\/thno.18136","article-title":"Surface De-PEGylation controls nanoparticle-mediated siRNA delivery in vitro and in vivo","volume":"7","author":"Zhu","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2013.07.059","article-title":"Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration","volume":"456","author":"Abu Lila","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0120","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1039\/D1SC06315D","article-title":"Redox dyshomeostasis strategy for tumor therapy based on nanomaterials chemistry","volume":"13","author":"Wu","year":"2022","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.06.023","article-title":"The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes","volume":"213","author":"Kierstead","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.progpolymsci.2018.01.002","article-title":"Polysarcosine-containing Copolymers: Synthesis, Characterization, Self-assembly, and Applications","volume":"81","author":"Birke","year":"2018","journal-title":"Progr. Polym. Sci."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0135","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1038\/s41467-018-07755-0","article-title":"Monitoring drug nanocarriers in human blood by near-infrared fluorescence correlation spectroscopy","volume":"9","author":"Negwer","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0140","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1021\/acs.macromol.8b00258","article-title":"Solution properties of polysarcosine: from absolute and relative molar mass determinations to complement activation","volume":"51","author":"Weber","year":"2018","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0145","doi-asserted-by":"crossref","first-page":"8646","DOI":"10.1021\/acsnano.8b04433","article-title":"Enhanced permeability and retention-like extravasation of nanoparticles from the vasculature into tuberculosis granulomas in zebrafish and mouse models","volume":"12","author":"Fenaroli","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0150","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4049\/jimmunol.83.2.193","article-title":"Antigenicity of polypeptides (Poly Alpha Amino Acids)","volume":"83","author":"Maurer","year":"1959","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0155","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.1021\/acsanm.0c01834","article-title":"Polysarcosine-functionalized lipid nanoparticles for therapeutic mRNA delivery","volume":"3","author":"Nogueira","year":"2020","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0160","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/1061186X.2014.997735","article-title":"PEG-lipid micelles as drug carriers: physiochemical attributes, formulation principles and biological implication","volume":"23","author":"Gill","year":"2015","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0165","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/pharmaceutics5040542","article-title":"Surface engineering of liposomes for stealth behavior","volume":"5","author":"Nag","year":"2013","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0170","first-page":"2801","article-title":"Comparative studies of polyethylene glycol-modified liposomes prepared using different PEG-modification methods","volume":"2012","author":"Nakamura","year":"1818","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0175","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2014.04.017","article-title":"Assessment of PEG on polymeric particles surface, a key step in drug carrier translation","volume":"185","author":"Rabanel","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0180","doi-asserted-by":"crossref","first-page":"20304","DOI":"10.1021\/acsami.8b22693","article-title":"Role of liposome size, surface charge, and PEGylation on rheumatoid arthritis targeting therapy","volume":"11","author":"Ren","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0185","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2006.10.029","article-title":"Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides","volume":"117","author":"Remaut","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0190","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1039\/b417091c","article-title":"The C- and N-terminal residues of synthetic heptapeptide ion channels influence transport efficacy through phospholipid bilayers","volume":"29","author":"Djedovi\u010d","year":"2005","journal-title":"New J. Chem.=Nouv. J. Chim."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0195","doi-asserted-by":"crossref","first-page":"6746","DOI":"10.1021\/ma201015y","article-title":"Polypeptoids from N-Substituted Glycine N-Carboxyanhydrides: Hydrophilic, Hydrophobic, and Amphiphilic Polymers with Poisson Distribution","volume":"44","author":"Fetsch","year":"2011","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0200","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1016\/j.biomaterials.2014.02.029","article-title":"On the biodegradability of polyethylene glycol, polypeptoids and poly(2-oxazoline)s","volume":"35","author":"Ulbricht","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0205","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1021\/bm401542z","article-title":"Polypeptoid-block-polypeptide copolymers: synthesis, characterization, and application of amphiphilic block copolypept(o)ides in drug formulations and miniemulsion techniques","volume":"15","author":"Birke","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0210","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1242\/dev.02087","article-title":"Cellular and molecular analyses of vascular tube and lumen formation in zebrafish","volume":"132","author":"Jin","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2019.109223","article-title":"Synthesis and characterization of bisalkylated polysarcosine-based lipopolymers","volume":"120","author":"Muhl","year":"2019","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0220","doi-asserted-by":"crossref","first-page":"15191","DOI":"10.1021\/acsnano.1c05713","article-title":"Density of conjugated antibody determines the extent of fc receptor dependent capture of nanoparticles by liver sinusoidal endothelial cells","volume":"15","author":"Kappel","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0225","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1021\/acs.langmuir.8b03829","article-title":"Shape and Phase Transitions in a PEGylated Phospholipid System","volume":"35","author":"Viitala","year":"2019","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0230","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0235","first-page":"4183","article-title":"Effects of PEG anchors in PEGylated siRNA lipoplexes on in vitro genesilencing effects and siRNA biodistribution in mice","volume":"22","author":"Hattori","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020272","article-title":"PEGylated versus Non-PEGylated pH-sensitive liposomes: new insights from a comparative antitumor activity study","volume":"14","author":"Nunes","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0245","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1208\/s12248-011-9298-1","article-title":"Relationships between liposome properties, cell membrane binding, intracellular processing, and intracellular bioavailability","volume":"13","author":"Li","year":"2011","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0255","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1081\/LPR-120020318","article-title":"Effect of Polyethyleneglycol (PEG) Chain on Cell Uptake of PEG-Modified Liposomes","volume":"13","author":"Sadzuka","year":"2003","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241006","article-title":"The effects of PEGylation on LNP based mRNA delivery to the eye","volume":"15","author":"Ryals","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0265","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jconrel.2017.08.023","article-title":"Zebrafish as an early stage screening tool to study the systemic circulation of nanoparticulate drug delivery systems in vivo","volume":"264","author":"Sieber","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0270","first-page":"1906719","article-title":"Zebrafish embryos allow prediction of nanoparticle circulation times in mice and facilitate quantification of nanoparticle\u2013cell","volume":"16","author":"Dal","year":"2020","journal-title":"Interactions"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0275","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1021\/acsnano.7b06995","article-title":"Directing nanoparticle biodistribution through evasion and exploitation of Stab2-dependent nanoparticle uptake","volume":"12","author":"Campbell","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0280","series-title":"In vivo Characterization of Microglial Engulfment of Dying Neurons in the Zebrafish Spinal Cord","volume":"9","author":"Morsch","year":"2015"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0285","doi-asserted-by":"crossref","first-page":"R371","DOI":"10.1016\/j.cub.2010.02.039","article-title":"Circuit neuroscience in zebrafish","volume":"20","author":"Friedrich","year":"2010","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037292","article-title":"Graph theoretical model of a sensorimotor connectome in zebrafish","volume":"7","author":"Stobb","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0295","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ntt.2011.08.013","article-title":"In vivo imaging and quantitative analysis of changes in axon length using transgenic zebrafish embryos","volume":"33","author":"Kanungo","year":"2011","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.jconrel.2023.02.021_bb0300","series-title":"Regeneration of Dopaminergic Neurons in Adult Zebrafish Depends on Immune System Activation and Differs for Distinct Populations","first-page":"4694","volume":"39","author":"Caldwell","year":"2019"},{"key":"10.1016\/j.jconrel.2023.02.021_bb0305","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuron.2019.04.034","article-title":"A cellular-resolution atlas of the larval zebrafish brain","volume":"103","author":"Kunst","year":"2019","journal-title":"Neuron"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923001311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923001311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:42:52Z","timestamp":1777509772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923001311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":60,"alternative-id":["S0168365923001311"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.02.021","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polysarcosine-based lipid formulations for intracranial delivery of mRNA","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}